TABLE 1.
Characteristics of Training and Validation Data
| Training Set (n = 4,860 | Validation Set (n = 2,084) | P | |
|---|---|---|---|
| Age (median [IQR]) | 56 (49‐62) | 55 (49‐62) | 0.022 |
| Gender female (%) | 1563 (32.2) | 659 (31.6) | 0.680 |
| Disease (%) | 0.089 | ||
| Cirrhosis, alcohol‐associated | 1,361 (28.0) | 600 (28.8) | |
| Cirrhosis, HCV | 352 (7.2) | 123 (5.9) | |
| Cirrhosis, other causes | 825 (17.0) | 353 (16.9) | |
| Cholestatic disease | 652 (13.4) | 295 (14.1) | |
| HCC and cirrhosis | 953 (19.6) | 421 (20.2) | |
| Other | 717 (14.8) | 292 (14.0) | |
| Status after 90 days | 0.508 | ||
| Censored because of HU or (N)SE | 1171 (24.2) | 476 (22.9) | |
| Deceased | |||
| While actively listed | 115 (2.4) | 59 (2.8) | |
| After removal but within 90 days | 337 (7.0) | 167 (8.0) | |
| Removed from the WL | 624 (12.8) | 257 (12.3) | |
| Still waiting on WL | 1734 (35.8) | 739 (35.5) | |
| Transplanted | 867 (17.9) | 381 (18.3) | |
| Days follow‐up (mean [SD]) | 44.22 (39.48) | 44.06 (39.27) | 0.875 |
| Serum measurement at listing (mean [SD]) | |||
| Creatinine (mg/dL) | 1.40 (3.73) | 1.46 (4.16) | 0.563 |
| Bilirubin (mg/dL) | 5.74 (8.79) | 5.84 (9.34) | 0.669 |
| INR | 1.51 (0.72) | 1.52 (0.72) | 0.510 |
| Sodium (mmol/L) | 137.02 (4.99) | 136.94 (4.88) | 0.526 |
| UNOS‐MELD at listing (median [IQR]) | 14 (10‐20) | 14 (10‐20) |